ArticleCurrent oncology (Toronto, Ont.)2016

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.

B Melosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.